Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. DE

Go back to Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone
LIPOCINE (NASDAQ: LPCN) Delayed: 2.09 --0 (-0%)
Previous Close $2.09    52 Week High $14.80 
Open $2.11    52 Week Low $2.51 
Day High $2.11    P/E N/A 
Day Low $2.06    EPS $-0.69 
Volume 18,218